Literature DB >> 20445501

Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.

Guofu Shen1, Bradley J Van Sickle, Elizabeth I Tietz.   

Abstract

Benzodiazepine withdrawal anxiety is associated with potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR) currents in hippocampal CA1 pyramidal neurons attributable to increased synaptic incorporation of GluA1-containing AMPARs. The contribution of calcium/calmodulin-dependent protein kinase II (CaMKII) to enhanced glutamatergic synaptic strength during withdrawal from 1-week oral flurazepam (FZP) administration was further examined in hippocampal slices. As earlier reported, AMPAR-mediated miniature excitatory postsynaptic current (mEPSC) amplitude increased in CA1 neurons from 1- and 2-day FZP-withdrawn rats, along with increased single-channel conductance in neurons from 2-day rats, estimated by non-stationary noise analysis. Input-output curve slope was increased without a change in paired-pulse facilitation, suggesting increased AMPAR postsynaptic efficacy rather than altered glutamate release. The increased mEPSC amplitude and AMPAR conductance were related to CaMKII activity, as intracellular inclusion of CaMKIINtide or autocamtide-2-related inhibitory peptide, but not scrambled peptide, prevented both AMPAR amplitude and conductance changes. mEPSC inhibition by 1-naphthyl acetyl spermine and the negative shift in rectification index at both withdrawal time points were consistent with functional incorporation of GluA2-lacking AMPARs. GluA1 but not GluA2 or GluA3 levels were increased in immunoblots of postsynaptic density (PSD)-enriched subcellular fractions of CA1 minislices from 1-day FZP-withdrawn rats, when mEPSC amplitude, but not conductance, was increased. Both GluA1 expression levels and CaMKII alpha-mediated GluA1 Ser(831) phosphorylation were increased in PSD-subfractions from 2-day FZP-withdrawn rats. As phospho-Thr(286)CaMKII alpha was unchanged, CaMKII alpha may be activated through an alternative signaling pathway. Synaptic insertion and subsequent CaMKII alpha-mediated Ser(831) phosphorylation of GluA1 homomers contribute to benzodiazepine withdrawal-induced AMPAR potentiation and may represent an important hippocampal pathway mediating both drug-induced and activity-dependent plasticity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445501      PMCID: PMC2904841          DOI: 10.1038/npp.2010.61

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  80 in total

1.  Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal.

Authors:  Paromita Das; Ricardo Zerda; Francisco J Alvarez; Elizabeth I Tietz
Journal:  J Comp Neurol       Date:  2010-11-01       Impact factor: 3.215

2.  Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism.

Authors:  P M Lledo; G O Hjelmstad; S Mukherji; T R Soderling; R C Malenka; R A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

3.  Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour.

Authors:  Guofu Shen; Mahmoud S Mohamed; Paromita Das; Elizabeth I Tietz
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

4.  Specific roles of AMPA receptor subunit GluR1 (GluA1) phosphorylation sites in regulating synaptic plasticity in the CA1 region of hippocampus.

Authors:  Hey-Kyoung Lee; Kogo Takamiya; Kaiwen He; Lihua Song; Richard L Huganir
Journal:  J Neurophysiol       Date:  2009-11-11       Impact factor: 2.714

5.  Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine.

Authors:  Jessica A Loweth; Bryan F Singer; Lorinda K Baker; Georgia Wilke; Hidetoshi Inamine; Nancy Bubula; John K Alexander; William A Carlezon; Rachael L Neve; Paul Vezina
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

6.  Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach.

Authors:  Wei Lu; Yun Shi; Alexander C Jackson; Kirsten Bjorgan; Matthew J During; Rolf Sprengel; Peter H Seeburg; Roger A Nicoll
Journal:  Neuron       Date:  2009-04-30       Impact factor: 17.173

7.  Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine.

Authors:  Amy C Boudreau; Carrie R Ferrario; Marc J Glucksman; Marina E Wolf
Journal:  J Neurochem       Date:  2009-05-03       Impact factor: 5.372

8.  Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation.

Authors:  Kaiwen He; Lihua Song; Laurel W Cummings; Jonathan Goldman; Richard L Huganir; Hey-Kyoung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

9.  Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period.

Authors:  M B Ghasemzadeh; C Mueller; P Vasudevan
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

10.  Plasticity of L-type Ca2+ channels after cocaine withdrawal.

Authors:  Kerstin A Ford; Marina E Wolf; Xiu-Ti Hu
Journal:  Synapse       Date:  2009-08       Impact factor: 2.562

View more
  8 in total

1.  Electrophysiological properties of hippocampal-cortical neural networks, role in the processes of learning and memory in rats.

Authors:  Chang-Jun Li; Yun Lu; Mei Zhou; Lian-Jun Guo
Journal:  J Neural Transm (Vienna)       Date:  2014-02-07       Impact factor: 3.575

2.  Increased expression of calcium/calmodulin-dependent protein kinase type II subunit δ after rat traumatic brain injury.

Authors:  Mingyang Zhang; Haiyan Shan; Zhenyong Gu; Donglin Wang; Tao Wang; Zhiwei Wang; Luyang Tao
Journal:  J Mol Neurosci       Date:  2011-11-03       Impact factor: 3.444

3.  Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal.

Authors:  Paromita Das; Ricardo Zerda; Francisco J Alvarez; Elizabeth I Tietz
Journal:  J Comp Neurol       Date:  2010-11-01       Impact factor: 3.215

4.  Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.

Authors:  Guofu Shen; Elizabeth I Tietz
Journal:  J Pharmacol Exp Ther       Date:  2010-10-08       Impact factor: 4.030

5.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

Review 6.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

7.  Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability.

Authors:  Jason R Klug; Brian N Mathur; Thomas L Kash; Hui-Dong Wang; Robert T Matthews; A J Robison; Mark E Anderson; Ariel Y Deutch; David M Lovinger; Roger J Colbran; Danny G Winder
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  Regulation of Ca²⁺/calmodulin-dependent protein kinase II signaling within hippocampal glutamatergic postsynapses during flurazepam withdrawal.

Authors:  Damien E Earl; Paromita Das; William T Gunning; Elizabeth I Tietz
Journal:  Neural Plast       Date:  2012-07-05       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.